Requires an issuer to submit certain prescription drug cost and utilization data to the office of financial management for the previous calendar year.

Requires a covered manufacturer to: (1) Report specific data to the office of financial management for each covered drug; and

(2) Notify purchasers and the office of financial management sixty days in advance of the introduction or price increase of a covered drug.